Non-inferiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical Ventilation

July 9, 2025 updated by: Mark Kendall, Rhode Island Hospital

Non-inferiority Comparative Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical Ventilation in Patients Undergoing Non-emergent Surgery With General Anesthesia

Effective respiratory ventilation is achieved by moving the right amount of air in and out of the lungs while keeping the pressures at a safe level. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery. In this non-inferiority study, we will perform a pre-post study design (single group, within-group comparison) to test the non-inferiority of the Adult Sotair® device compared to mechanical ventilation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Poor manual ventilation technique is a well-documented problem which occurs irrespective of a provider's qualifications or experience. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery among providers. The device is attached to a bag valve mask (i.e. manual resuscitator) and employs a flow limiting valve mechanism to minimize excessive pressure in the airway system without venting air by capping peak flow rates at 55 L/min. For an average adult with normal lung compliance and resistance, this corresponds to a maximum airway pressure of approximately 20 cmH2O which minimizes air entry into the stomach. In this non-inferiority study, a pre-post study design (single group, within-group comparison) to test the non-inferiority of the Adult Sotair® device compared to mechanical ventilation with respect to airway pressure.

Study Type

Interventional

Enrollment (Estimated)

310

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Rhode Island
      • Providence, Rhode Island, United States, 02903

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients who are scheduled for non-emergency surgery with general anesthesia at Rhode Island Hospital.
  • American Society of Anesthesiologists physical status 1 and 2

Exclusion Criteria:

  • ASA PS >3 (e.g., respiratory disease)
  • Oropharyngeal or facial pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Bag mask ventilation with Adult Sotair device
The anesthesia provider will manually bag ventilate with the Adult Sotair® device for 3 minutes.
Sotair® device employs a flow limiting and pressure control valve mechanism.
Other Names:
  • Sotair
  • SafeBVM
No Intervention: Mechanical Ventilation
The anesthesia provider will remove the bag valve mask and Adult Sotair® device and connect the patient to the mechanical ventilator. The recording of pressure and flow will last for 3 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak airway pressure
Time Frame: Recorded for 3 minute duration for each arm of the study
mean peak airway pressure expressed in cm H20
Recorded for 3 minute duration for each arm of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tidal volume
Time Frame: Recorded for 3 minute duration for each arm of the study
The amount of air that moves in or out of the lungs with each respiratory cycle. Measured in mL.
Recorded for 3 minute duration for each arm of the study
Airflow
Time Frame: Recorded for 3 minute duration for each arm of the study
Represents the volume of air moved per unit of time during inspiration and expiration. Measured s
Recorded for 3 minute duration for each arm of the study
Respiratory rate
Time Frame: Recorded for 3 minute duration for each arm of the study
The number of breaths. Measured as breaths per minute.
Recorded for 3 minute duration for each arm of the study
Oxygen saturation (SpO2)
Time Frame: Recorded for 3 minute duration for each arm of the study
A present of oxygen-bound hemoglobin in the blood.
Recorded for 3 minute duration for each arm of the study
End Tidal CO2
Time Frame: Recorded for 3 minute duration for each arm of the study
The level of carbon dioxide at the end of an exhaled breath. Expressed as a percentage of CO2 or mmHg.
Recorded for 3 minute duration for each arm of the study
Blood pressure
Time Frame: Recorded for 3 minute duration for each arm of the study
Is the measurement of the pressure or force of blood inside your arteries. Measured as mm Hg.
Recorded for 3 minute duration for each arm of the study
Heart rate
Time Frame: Recorded for 3 minute duration for each arm of the study
The number of times your heart beats per minute. Measured as beats per minute.
Recorded for 3 minute duration for each arm of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mark Kendall, MD, Rhode Island Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2023

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

October 31, 2023

First Submitted That Met QC Criteria

October 31, 2023

First Posted (Actual)

November 7, 2023

Study Record Updates

Last Update Posted (Actual)

July 11, 2025

Last Update Submitted That Met QC Criteria

July 9, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The IPD that underlie results in a publication will be shared with other researchers.

IPD Sharing Time Frame

The SAP will be available at the end of the trial for three years. The data that supports the findings of this study will be available from the corresponding investigator upon reasonable request.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Clinical Trials on ADULT Sotair Device

Subscribe